求助7篇文献 不胜感激

aaaszw

& _" i6 V6 p3 M+ D4 `( g" y
3 Z% V3 H8 I" c) d. d; z* x
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.2 V9 L- w2 Y9 n
https://www.ncbi.nlm.nih.gov/pubmed/27912061- a" y: U; `1 H  g/ O, u
/ _8 F5 {5 d; p
The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
5 E! d9 P( i+ E4 w2 K' x! ihttps://www.ncbi.nlm.nih.gov/pubmed/27525555. y4 o% f! O+ x+ y' }
3 J1 [+ N) @, f7 v
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion$ ?" G' j) M; M6 m6 O5 S
https://www.ncbi.nlm.nih.gov/pubmed/27496729, {$ r" E) A2 I9 m$ f" h
% I3 l3 H3 M: h3 Z( z
Cutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.5 v6 N. M* Z  Z0 i$ S) N0 g
https://www.ncbi.nlm.nih.gov/pubmed/27430722( H6 j% P0 ]( o8 a8 v0 x0 _" C

9 `$ F; c/ c/ v7 G( ^3 r! ]Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease." M/ u; k0 `6 C$ I! b) Z9 I
https://www.ncbi.nlm.nih.gov/pubmed/27192569
' d' J1 I7 ~+ M6 u/ k* Y5 n* i2 ^& \9 C4 w9 ^
Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling  Z7 J( l# o8 x$ i# ]
https://www.ncbi.nlm.nih.gov/pubmed/27058661" J  y# S8 b9 s' e  _: z' E

. Q7 O  \/ o. JDe-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
9 J, ~$ ^7 b4 S5 j; r) j4 ]7 nhttps://www.ncbi.nlm.nih.gov/pubmed/27036972

lchanlon

回复 aaaszw 的帖子0 b* ?' s! O* d1 ?% }
9 c% Z) B2 o( v  g6 [6 v1 Q5 j
Here you go
# T% i, H" v8 Z8 b; x! I% ^/ r( M: {) v$ K6 m1 C/ f2 `% O0 p
Good luck!

lchanlon

回复 aaaszw 的帖子- O8 F  d$ R4 F4 H

1 Y1 W+ q" ]6 O1 S( q/ OHere you go * n; |' Y: `# R. h# d5 |# O

* g+ H2 c. I5 ~7 RGood luck!

aaaszw

回复 lchanlon 的帖子$ j6 n& r$ d  Z6 n

  j! T! \8 Z0 O- D9 `$ O* [merci beaucoup ：）